Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hepatitis C × Infliximab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1 Dermatologic 1

Conditions

Arthritis, Rheumatoid 4 Inflammatory Bowel Diseases 2 Colitis, Ulcerative 2 Spondylitis, Ankylosing 1 Psoriasis 1 Precancerous Conditions 1 Melanoma 1 Infections 1 Hepatitis C 1 Crohn Disease 1 Arthritis 1

Interventions

tremelimumab 1 Ribavirin 1 Infliximab 1 Chromatography, High Pressure Liquid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡